Elastin-Like Polypeptide Delivers a Notch Inhibitory Peptide to Inhibit Tumor Growth in Combination with Paclitaxel

J Chemother. 2019 Feb;31(1):23-29. doi: 10.1080/1120009X.2018.1537554.

Abstract

This research describes a thermally responsive elastin-like polypeptide (ELP) for the delivery of dnMAML peptides that inhibit the Notch pathway. Exploiting passive targeting and a thermally active tumor-targeting technique available through the use of ELP, the dnMAML peptide was efficiently delivered to tumor tissue. Furthermore, this ELP-dnMAML was modified with the addition of a cell penetrating peptide (SynB1) for improved infiltration of ELP-dnMAML into the tumor cells. In this study, we verified that intravenously delivered SynB1-ELP-dnMAML was cleared from circulation under physiological conditions (37 °C) but accumulated at tumors grown in mice at sites to which an externally induced, local heat (40-41 °C) was applied, thereby resulting in greatly reduced tumor growth in animals. Additionally, in combination with Taxol, SynB1-ELP-dnMAML showed more potent tumor growth retardation.

Keywords: Anticancer; Cell penetrating peptide; Elastin-like polypeptide; Notch pathway; dnMAML.

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic
  • Cell Line, Tumor
  • Cell-Penetrating Peptides
  • DNA-Binding Proteins / administration & dosage*
  • Drug Delivery Systems*
  • Female
  • Humans
  • Hyperthermia, Induced
  • Mammary Neoplasms, Experimental / pathology*
  • Mice
  • Mice, Nude
  • Paclitaxel / administration & dosage*
  • Peptides / administration & dosage*
  • Receptors, Notch / antagonists & inhibitors*
  • Transcription Factors / administration & dosage*
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents, Phytogenic
  • Cell-Penetrating Peptides
  • DNA-Binding Proteins
  • MAML1 protein, human
  • Peptides
  • Receptors, Notch
  • Transcription Factors
  • elastin polypentapeptide
  • Paclitaxel